Application 202360
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ETOMIDATE | ETOMIDATE | INJECTABLE;INJECTION | 2MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65841-818 | etomidate | etomidate | Zydus Lifesciences Limited | ANDA | Current |
| 65841-818 | etomidate | etomidate | Cadila Healthcare Limited | ANDA | Current |
| 65841-818 | etomidate | etomidate | Cadila Healthcare Limited | ANDA | Current |
| 65841-818 | etomidate | etomidate | Cadila Healthcare Limited | ANDA | Current |
| 68382-545 | etomidate | etomidate | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 68382-545 | etomidate | etomidate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-545 | etomidate | etomidate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |